Article
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients.
Journal of affective disorders - 1 Dec 2009
Mandelli Laura, Mazza Marianna, Martinotti Giovanni, Di Nicola Marco, Tavian Daniela, Colombo Elisa, Missaglia Sara, De Ronchi Diana, Colombo Roberto, Janiri Luigi, Serretti Alessandro
Abstract excerpt
Response to pharmacological treatments is moderated by both genetic and environmental factors. The contribution of such factors is relatively small and complex interactions are likely to be involved. Serotonin transporter gene (SLC6A4) is a major candidate gene associated to response to antidepressant treatment. Moreover, the 5-HTTLPR polymorphism has been associated with anxiety-related traits such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
